Alzheimer's disease

被引:2476
作者
Lane, C. A. [1 ]
Hardy, J. [2 ]
Schott, J. M. [1 ]
机构
[1] UCL Inst Neurol, Dementia Res Ctr, London, England
[2] UCL Inst Neurol, Reta Lila Weston Res Labs, Dept Mol Neurosci, London, England
基金
英国工程与自然科学研究理事会; 欧盟地平线“2020”; “创新英国”项目;
关键词
Alzheimer's disease; epidemiology; genetics; pathogenesis; pathology; treatment; MILD COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; AMYLOID HYPOTHESIS; NEUROPATHOLOGIC ASSESSMENT; MICROGLIAL ACTIVATION; BLOOD BIOMARKERS; NATURAL-HISTORY; BETA PLAQUES;
D O I
10.1111/ene.13439
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Alzheimer's disease, the commonest cause of dementia, is a growing global health concern with huge implications for individuals and society. In this review, current understanding of the epidemiology, genetics, pathology and pathogenesis of Alzheimer's disease is outlined, before its clinical presentation and current treatment strategies are discussed. Finally, the review discusses how our enhanced understanding of Alzheimer pathogenesis, including the recognition of a protracted preclinical phase, is informing new therapeutic strategies with the aim of moving from treatment to prevention.
引用
收藏
页码:59 / 70
页数:12
相关论文
共 77 条
[1]
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
Albert, Marilyn S. ;
DeKosky, Steven T. ;
Dickson, Dennis ;
Dubois, Bruno ;
Feldman, Howard H. ;
Fox, Nick C. ;
Gamst, Anthony ;
Holtzman, David M. ;
Jagust, William J. ;
Petersen, Ronald C. ;
Snyder, Peter J. ;
Carrillo, Maria C. ;
Thies, Bill ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :270-279
[2]
Alzheimer A., 1907, Zentralbl. Nervenh. Psych, V64, P146, DOI DOI 10.1002/CA.980080612
[3]
Antipsychotic drugs for dementia: a balancing act [J].
不详 .
LANCET NEUROLOGY, 2009, 8 (02) :125-125
[4]
[Anonymous], 2002, Cochrane Database Syst. Rev, DOI DOI 10.1002/14651858.CD003944
[5]
[Anonymous], 2016, Drinking Water Health Advisory for Perfluorooctanoic Acid (PFOA), P1
[6]
Neuroleptic drugs in dementia: benefits and harm [J].
Ballard, Clive ;
Howard, Robert .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (06) :492-500
[7]
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease [J].
Bateman, Randall J. ;
Xiong, Chengjie ;
Benzinger, Tammie L. S. ;
Fagan, Anne M. ;
Goate, Alison ;
Fox, Nick C. ;
Marcus, Daniel S. ;
Cairns, Nigel J. ;
Xie, Xianyun ;
Blazey, Tyler M. ;
Holtzman, David M. ;
Santacruz, Anna ;
Buckles, Virginia ;
Oliver, Angela ;
Moulder, Krista ;
Aisen, Paul S. ;
Ghetti, Bernardino ;
Klunk, William E. ;
McDade, Eric ;
Martins, Ralph N. ;
Masters, Colin L. ;
Mayeux, Richard ;
Ringman, John M. ;
Rossor, Martin N. ;
Schofield, Peter R. ;
Sperling, Reisa A. ;
Salloway, Stephen ;
Morris, John C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :795-804
[8]
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease [J].
Bateman, Randall J. ;
Aisen, Paul S. ;
De Strooper, Bart ;
Fox, Nick C. ;
Lemere, Cynthia A. ;
Ringman, John M. ;
Salloway, Stephen ;
Sperling, Reisa A. ;
Windisch, Manfred ;
Xiong, Chengjie .
ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (01)
[9]
Cholinesterase inhibitors for Alzheimer's disease [J].
Birks, J .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01)
[10]
NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259